ANGPTL8 and nonpapillary renal cell carcinoma: Thus, it is necessary to experimentally validate both the gene and protein expression of ANGPTL8/betatrophin in ccRCC/KIRC patients as well as investigate the expression of ANGPTL8/betatrophin in the above-mentioned cancers grouped into those categories.